Scroll Top

Phakic IOL

Phakic IOL Implantation

A phakic IOL is best indicated in patients with a centered cone and good BCVA. Patients tend to achieve greater independence from glasses or contact lenses compared to other surgical visual rehabilitation techniques and a higher satisfaction rate. We have a slight preference for this procedure in patients with high refractive errors.

Phakic IOL with CXL

This combination therapy is mandatory in young patients with progressive Keratoconus and high myopia. The refractive outcome is predictable and there are almost no side effects.

Non-surgical treatments that get results.

Precision’s keratoconus treatment protocol varies depending on each patient’s individual needs, and may include scleral contact lenses, other specialty contact lenses, and dry eye treatments. With appropriate treatment, 20/20 vision can be restored for patients with keratoconus.

Importantly, our doctors focus on non-surgical treatment options. Many of our patients have been recommended by other doctors to undergo surgery, such as corneal transplants, corneal implants (Intacs), or corneal collagen cross-linking (CXL). Precision’s non-surgical treatment protocol has resulted in restored vision for many of these patients. Additionally, many patients who have already undergone these surgeries still have vision issues and now turn to Precision for help.

Although these surgical procedures are successful for some patients, we always recommend getting a second opinion to determine whether non-surgical keratoconus treatment options to restore vision may be best for you.

Why do keratoconus patients continue to suffer?

The main reason why keratoconus patients continue to suffer from their symptoms is the lack of an adequate evaluation and treatment protocol from experienced doctors. Most patients seeking Precision’s assistance have seen several other eye care practitioners before coming to us. A meticulous, detailed evaluation is vital to tailoring a successful treatment program that will restore your vision.